Crucially, DUX4 target genes, the three validated DUX4 target gene signatures, MRI and histopathology measures failed to change in a cohort of FSHD patients with 1-year follow-up [176, 177]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.